Increasing Operational Capacity For Gene Therapies

  • Taking a look at Valoctocogene Roxaparvovec gene therapy for Hemophilia A
  • Where is BioMarin in its Valrox manufacturing readiness campaign?
  • Understanding the complexities of manufacturing and the supply chain for gene therapy products
  • Partnering for success: Examining recent collaborations to help advance technology innovation and timelines

Leave a reply

Please enter your comment!
Please enter your name here